Holen Sie sich die Stockscreener-App
0.768
5.87%
-0.0479
Handel nachbörslich:
.72
-0.048
-6.25%
Pasithea Therapeutics Corp Aktie (KTTA) Neueste Nachrichten
Multi factor analysis applied to Pasithea Therapeutics Corp.Stop Loss & Fast Gaining Stock Strategy Reports - newser.com
Real time social sentiment graph for Pasithea Therapeutics Corp. Equity WarrantQuarterly Portfolio Review & Breakout Confirmation Trade Signals - newser.com
Pasithea activates new clinical trial site for NF1 treatment study - Investing.com
Pasithea Therapeutics Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients - Investing News Network
Pasithea Therapeutics Opens New Trial Site for PAS-004 - TipRanks
Pasithea Therapeutics Activates New Clinical Trial Site at UAB for PAS-004 Study in Neurofibromatosis Type 1 Patients - Quiver Quantitative
Pasithea (NASDAQ: KTTA) opens UAB site; enrollment begins in Phase 1/1b PAS-004 NF1 study - Stock Titan
Can Pasithea Therapeutics Corp. Equity Warrant stock beat market expectations this quarterShare Buyback & Free Daily Entry Point Trade Alerts - newser.com
Why retail investors pile into Pasithea Therapeutics Corp. Equity Warrant stockJuly 2025 Selloffs & Consistent Income Trade Ideas - newser.com
Pasithea Therapeutics Corp. stock trend forecastGap Up & Consistent Profit Focused Trading Strategies - newser.com
Will Pasithea Therapeutics Corp. stock outperform tech sector in 20252025 Institutional Moves & Weekly High Potential Alerts - newser.com
Can Pasithea Therapeutics Corp. stock outperform in 2025 bull marketBull Run & Daily Stock Momentum Reports - newser.com
Does Pasithea Therapeutics Corp. Equity Warrant qualify in momentum factor screeningShare Buyback & AI Enhanced Market Trend Forecasts - newser.com
Does Pasithea Therapeutics Corp. Equity Warrant stock trade at a discount to peers - newser.com
Combining price and volume data for Pasithea Therapeutics Corp.2025 Market Sentiment & Short-Term High Return Ideas - newser.com
Pasithea Therapeutics Corp. Equity Warrant stock trend forecast2025 Short Interest & Fast Gaining Stock Reports - newser.com
Comparing Pasithea Therapeutics Corp. Equity Warrant in custom built stock radarsQuarterly Trade Summary & Daily Entry Point Alerts - newser.com
Real time scanner hits for Pasithea Therapeutics Corp. Equity Warrant explainedVolume Spike & Long-Term Safe Investment Plans - newser.com
Custom strategy builders for tracking Pasithea Therapeutics Corp.Market Growth Summary & Real-Time Sentiment Analysis - newser.com
Is it too late to sell Pasithea Therapeutics Corp.Jobs Report & Short-Term Swing Trade Alerts - newser.com
Pasithea Therapeutics Corp. Equity Warrant stock daily chart insightsQuarterly Profit Review & Expert Approved Momentum Ideas - newser.com
Pasithea Therapeutics Corp.’s volatility index tracking explainedEntry Point & Verified Momentum Watchlists - newser.com
Is Pasithea Therapeutics Corp. Equity Warrant stock supported by strong cash flows2025 Market Trends & Low Drawdown Investment Ideas - newser.com
Has Pasithea Therapeutics Corp. formed a bullish divergence2025 Top Decliners & Technical Buy Zone Confirmations - newser.com
Chart based analysis of Pasithea Therapeutics Corp. Equity Warrant trendsJuly 2025 News Drivers & Entry and Exit Point Strategies - newser.com
Understanding Pasithea Therapeutics Corp. Equity Warrant’s price movementEarnings Overview Summary & Daily Profit Maximizing Tips - newser.com
Backtesting results for Pasithea Therapeutics Corp. Equity Warrant trading strategies2025 Bull vs Bear & Smart Money Movement Alerts - newser.com
Is Pasithea Therapeutics Corp. Equity Warrant stock positioned for long term growth2025 Market Outlook & Momentum Based Trading Signals - newser.com
Will breakout in Pasithea Therapeutics Corp. lead to full recovery2025 Support & Resistance & Daily Profit Maximizing Trade Tips - newser.com
What institutional flow reveals about Pasithea Therapeutics Corp. Equity Warrant2025 Earnings Impact & Reliable Trade Execution Plans - newser.com
Automated trading signals detected on Pasithea Therapeutics Corp. Equity Warrant2025 EndofYear Setup & Trade Opportunity Analysis - newser.com
Is Pasithea Therapeutics Corp. stock cheap compared to fundamentalsEarnings Recap Summary & Daily Stock Momentum Reports - newser.com
What earnings revisions data tells us about Pasithea Therapeutics Corp.Swing Trade & Proven Capital Preservation Tips - newser.com
Is Pasithea Therapeutics Corp. stock a dividend growth opportunityJuly 2025 Sector Moves & Growth Focused Stock Reports - newser.com
Is Pasithea Therapeutics Corp. stock a safe investment in uncertain marketsTreasury Yields & Weekly Market Pulse Updates - newser.com
Will Pasithea Therapeutics Corp. Equity Warrant stock outperform value stocksJuly 2025 Opening Moves & Intraday High Probability Alerts - newser.com
Is Pasithea Therapeutics Corp. stock a buy for dividend growthEarnings Risk Report & Low Risk Profit Maximizing Plans - newser.com
Why Pasithea Therapeutics Corp. Equity Warrant stock is trending among retail tradersJuly 2025 Levels & Reliable Breakout Forecasts - newser.com
Has Pasithea Therapeutics Corp. Equity Warrant found a price floorJuly 2025 Action & Community Consensus Picks - newser.com
Will Pasithea Therapeutics Corp. Equity Warrant stock continue dividend increasesMarket Sentiment Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Short interest data insights for Pasithea Therapeutics Corp.Quarterly Investment Review & Reliable Breakout Forecasts - newser.com
Why Pasithea Therapeutics Corp. stock is favored by top institutionsJuly 2025 Earnings & Precise Buy Zone Identification - newser.com
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):